#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Carcinoid tumour Isodicentric chromosome 15 syndrome Necrotising myositis Pericarditis Arrhythmia Malignant peritoneal neoplasm Ischaemic stroke Ehlers-Danlos syndrome Acute promyelocytic leukaemia Epstein-Barr virus infection Huntington's disease Aicardi-Goutieres syndrome Glomerulonephritis Kearns-Sayre syndrome Acute hepatic failure More trials…

    Learn about Rare Diseases

    Retinoblastoma – Treatment Angiosarcoma – Diagnostics Congenital hypotransferrinaemia – Trials in Disease Hereditary hypophosphataemic rickets – Diagnostics Testicular leiomyosarcoma – Diagnostics Paroxysmal nocturnal haemoglobinuria – Life with Disease Primary biliary cholangitis – Treatment Synovial sarcoma metastatic – Trials in Disease MELAS syndrome – Diagnostics Toxic epidermal necrolysis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rbl015.2 Inupadenant Hydrochloride Azd7798 Amsacrine GRAPHITE Acetic Acid, Glacial Ammonium Chloride Bp Wt1 Mrna Dc Panobinostat Dexibuprofen Keto-Leucine Calcium Zinc Acexamate Mva-209-Fsp-B2 Ptc518 Vibostolimab Petrelintide RO7795081 Defactinib Clofarabine Lonvoguran More therapies…

    Learn about Your Condition

    Lymphocytic leukaemia Pouchitis Lichen planopilaris Malignant fibrous histiocytoma Perineal injury Bone marrow disorder Left ventricular dysfunction Gout Cardiac failure acute Hyperparathyroidism secondary Septic shock Acoustic neuroma Peritoneal dialysis Haemorrhage prophylaxis Bladder cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Prive Jean Mermoz

Hopital Prive Jean Mermoz

55 Avenue Jean Mermoz, Lyon, 69008, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing XL092 and Atezolizumab with Regorafenib for Patients with Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Atezolizumab
    • Regorafenib
    Belgium France Germany Hungary Poland Portugal +1

  • Study Comparing Chemotherapy and Abemaciclib with Hormone Therapy for Patients with ER+ HER2- Metastatic Breast Cancer with Visceral Involvement

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    • Breast cancer metastatic
    Investigated Drugs:
    • Abemaciclib
    • Anastrozole
    • Capecitabine
    France

  • Study of Ribociclib and Letrozole for Patients with High-Risk Estrogen Receptor-Positive, HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Letrozole
    • Ribociclib
    France Spain

  • Study of ALX148 with Trastuzumab, Ramucirumab, and Paclitaxel for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Paclitaxel
    • Ramucirumab
    • Trastuzumab
    Belgium Czechia France Italy Spain

  • Study of Tislelizumab, Pamiparib, and Ociperlimab in Patients with Advanced Solid Tumors and Blood Cancers

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Haematological malignancy
    • Neoplasm malignant
    Investigated Drugs:
    • Ociperlimab
    • Pamiparib
    • Tislelizumab
    France Italy Poland

  • Study of tucatinib, pertuzumab and trastuzumab combination for patients with HER2-positive metastatic breast cancer who have brain metastases after local therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Tucatinib
    • Anastrozole
    • Exemestane
    France

  • Comparing drug combinations with panitumumab for patients with RAS and B-RAF wild-type metastatic colorectal cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Calcium Levofolinate
    • Panitumumab
    • Fluorouracil
    France

  • Study on Chemotherapy with Paclitaxel, Cisplatin, and Carboplatin for Patients with Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage I
    • Non-small cell lung cancer stage II
    • Lung neoplasm malignant
    Investigated Drugs:
    • Vinorelbine Tartrate
    • Carboplatin
    • Cisplatin
    France Germany

  • Study of Durvalumab with Chemoradiation Therapy for Patients with Locally Advanced, Unresectable Esophageal Squamous Cell Carcinoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Oesophageal squamous cell carcinoma
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Durvalumab
    Belgium France Poland Spain

  • Study of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Dostarlimab
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Denmark Finland France Germany +7
Previous Page
1 … 6 7 8 9 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!